National Penn Investors Trust’s AbbVie ABBV Stock Holding History

National Penn Investors Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$460K	Buy	8,050 +1,705	+27%	+$95K	0.05%	143
2015 Q4	$375K	Sell	6,345 -30	-0.5%	-$1.73K	0.04%	156
2015 Q3	$347K	Sell	6,375 -40	-0.6%	-$2.6K	0.04%	156
2015 Q2	$431K	Sell	6,415 -325	-5%	-$21.2K	0.05%	155
2015 Q1	$395K	Buy	6,740 +75	+1%	+$4.53K	0.04%	156
2014 Q4	$436K	Sell	6,665 -35	-0.5%	-$2.21K	0.05%	131
2014 Q3	$387K	Sell	6,700 -660	-9%	-$36.6K	0.05%	134
2014 Q2	$416K	Sell	7,360 -682	-8%	-$35.8K	0.05%	136
2014 Q1	$414K	Sell	8,042 -316	-4%	-$16K	0.05%	141
2013 Q4	$442K	Buy	8,358 +448	+6%	+$22K	0.05%	147
2013 Q3	$354K	Buy	7,910 +230	+3%	+$10.2K	0.04%	158
2013 Q2	$317K	Buy	+7,680	New	+$336K	0.04%	164

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

National Penn Investors Trust's ABBV Position: Q1 2016 in Review

National Penn Investors Trust increased its AbbVie (ABBV) stake by 27% in Q1 2016, buying an estimated $95K and bringing the position to 8,050 shares worth $460K. The position accounts for 0.05% of the portfolio, ranked #143.

National Penn Investors Trust first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. 1,639 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

National Penn Investors Trust held 8,050 shares of AbbVie worth $460K as of Q1 2016.
National Penn Investors Trust bought 1,705 AbbVie shares in Q1 2016, an estimated $95K.
AbbVie made up 0.05% of National Penn Investors Trust's portfolio in Q1 2016, its #143 holding.
National Penn Investors Trust first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
1,639 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on National Penn Investors Trust's 13F filing for Q1 2016, filed 11 May 2016.